Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure

International Journal of Cardiology

Volumn 175, Issue 1, 2014, Pages 83-89

  Poelzl, G ^a   Altenberger, J ^b,o   Pacher, R ^c   Ebner, C H ^d   Wieser, M ^e   Winter, A ^f   Fruhwald, F ^g   Dornaus, C ^h   Ehmsen, U ⁱ   Reiter, S ^j   Steinacher, R ^b   Huelsmann, M ^c   Eder, V ^d   Boehmer, A ^e   Pilgersdorfer, L ^f   Ablasser, K ^g   Keroe, D ⁱ   Groebner, H ^k   Auer, J ^l   Jakl, G ^m   Hallas, A ⁿ   Ess, M ^a   Ulmer, H ^a   more..

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Hospital of St Elisabeth   (Austria)

^e Department of Cardiology Krems General Hospital   (Austria)

^f Hospital of the Sisters of Charity   (Austria)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h HANUSCH HOSPITAL   (Austria)

ⁱ Physician in Private Practice   (Austria)

^j KAISER FRANZ JOSEF HOSPITAL   (Austria)

^k St Johanns Spital   (Austria)

^l Cardiology and Intensive Care General Hospital Braunau   (Austria)

^m WILHELMINEN HOSPITAL   (Austria)

ⁿ Department of Internal Medicine and Cardiology Donauklinikum Tulln ^*  (Austria)

^o Pensionsversicherungsanstalt Austria   (Austria)

more..

Author keywords

Chronic heart failure; Guideline adherence indicator; Prognosis; Treatment adjustment

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST; CARDIOVASCULAR AGENT;

ADULT; AGED; ARTICLE; AUSTRIA; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATION; DISEASE CLASSIFICATION; DISEASE REGISTRY; DOSE CALCULATION; DRUG CONTRAINDICATION; DRUG DOSE ESCALATION; DRUG INDICATION; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HOSPITALIZATION; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROGNOSIS; PROSPECTIVE STUDY; PROTOCOL COMPLIANCE; SURVIVAL RATE; SYSTOLIC HEART FAILURE; AUSTRALIA; CHRONIC DISEASE; EPIDEMIOLOGY; MEDICATION COMPLIANCE; MIDDLE AGED; REGISTER; TRENDS;

AGED; AUSTRALIA; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MORTALITY; REGISTRIES;

EID: 84902533656     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.04.255     Document Type: Article

References (22)

1. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 2012 2012 1787 1847
2. S.A. Hunt, W.T. Abraham, and M.H. Chin et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
3. M.J. Lenzen, E. Boersma, and W.J. Reimer et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure Eur Heart J 26 2005 2706 2713
4. P. de Groote, R. Isnard, and P. Clerson et al. Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme Eur J Heart Fail 11 2009 85 91
5. J.G. Cleland, A. Cohen-Solal, and J.C. Aguilar et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey Lancet 360 2002 1631 1639
6. M. Komajda, F. Follath, and K. Swedberg et al. The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment Eur Heart J 24 2003 464 474
7. F.M. Fruhwald, P. Rehak, R. Maier, N. Watzinger, M. Wonisch, and W. Klein Austrian survey of treating heart failure-AUSTRIA Eur J Heart Fail 6 2004 947 952
8. A. Gjesing, M. Schou, and C. Torp-Pedersen et al. Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care Eur J Heart Fail 15 2013 671 678
9. G.C. Fonarow, C.W. Yancy, and N.M. Albert et al. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF Circ Heart Fail 1 2008 98 106
10. M. Komajda, O. Hanon, and M. Hochadel et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II Eur Heart J 30 2009 478 486
11. S. Stork, H.W. Hense, and C. Zentgraf et al. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study Eur J Heart Fail 10 2008 1236 1245
12. A.P. Maggioni, U. Dahlstrom, and G. Filippatos et al. EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) Eur J Heart Fail 15 2013 808 817
13. L. Frankenstein, A. Remppis, and A. Fluegel et al. The association between long-term longitudinal trends in guideline adherence and mortality in relation to age and sex Eur J Heart Fail 12 2010 574 580
14. F. Peters-Klimm, T. Muller-Tasch, A. Remppis, J. Szecsenyi, and D. Schellberg Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice-results from a cluster-randomized controlled trial of implementation of a clinical practice guideline J Eval Clin Pract 14 2008 823 829
15. M. Komajda, P. Lapuerta, and N. Hermans et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey Eur Heart J 26 2005 1653 1659
16. F.M. Fruhwald, H. Ulmer, and R. Pacher et al. Heart rate and functional impairment are predictors of outcome in heart failure patients in the real world. Data from the Austrian Heart Failure registry Wien Klin Wochenschr 123 2011 378 383
17. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2 Suppl. 1 2002 S1 S266
18. K. Dickstein, A. Cohen-Solal, and G. Filippatos et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
19. G.M. Felker, L.K. Shaw, and C.M. O'Connor A standardized definition of ischemic cardiomyopathy for use in clinical research J Am Coll Cardiol 39 2002 210 218
20. G.C. Fonarow, N.M. Albert, and A.B. Curtis et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) Circulation 122 2010 585 596
21. J.T. Heywood, G.C. Fonarow, and C.W. Yancy et al. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF Circ Heart Fail 3 2010 596 605
22. A.B. Curtis, C.W. Yancy, and N.M. Albert et al. Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF Am Heart J 158 2009 956 964